These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients. Prins JM; Weverling GJ; van Ketel RJ; Speelman P Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024 [TBL] [Abstract][Full Text] [Related]
24. Comparative study by scanning electron microscopy on vestibular toxicities of dibekacin, ribostamycin, and other aminoglycoside antibiotics in guinea pigs. Sato K; Saito T; Matsuhira T Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):109-14. PubMed ID: 6602100 [TBL] [Abstract][Full Text] [Related]
26. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice. Ogier JM; Lockhart PJ; Burt RA Hear Res; 2020 Feb; 386():107870. PubMed ID: 31864009 [TBL] [Abstract][Full Text] [Related]
27. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service. Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and renal toxicity of one daily dose of amikacin versus conventional dosage regime. Guadalupe Vásquez-Mendoza M; Vargas-Origel A; Del Carmen Ramos-Jiménez A; Aguilar-Orozco G; Romero-Gutiérrez G Am J Perinatol; 2007 Feb; 24(2):141-6. PubMed ID: 17304422 [TBL] [Abstract][Full Text] [Related]
29. Aminoglycoside toxicity in neonates: something to worry about? Kent A; Turner MA; Sharland M; Heath PT Expert Rev Anti Infect Ther; 2014 Mar; 12(3):319-31. PubMed ID: 24455994 [TBL] [Abstract][Full Text] [Related]
30. [Vestibulometry in prognosis of lesions of the organ of hearing after administration of aminoglycoside antibiotics]. Bazarov VG; Mishchanchuk NS Zh Ushn Nos Gorl Bolezn; 1978; (6):21-7. PubMed ID: 216180 [No Abstract] [Full Text] [Related]
32. Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides. Chen KS; Bach A; Shoup A; Winick NJ Pediatr Blood Cancer; 2013 Nov; 60(11):1772-7. PubMed ID: 23788258 [TBL] [Abstract][Full Text] [Related]
33. [In the search for effective and safe dose of amikacin in patients with chronic kidney disease]. Gomółka M; Szamotulska K; Rymarz A; Brodowska-Kania D; Dubchak I; Piechota W; Jurkiewicz D; Niemczyk S Pol Merkur Lekarski; 2014 Apr; 36(214):240-4. PubMed ID: 24868895 [TBL] [Abstract][Full Text] [Related]
34. Self-protection against aminoglycoside ototoxicity in guinea pigs. Oliveira JA; Canedo DM; Rossato M; Andrade MH Otolaryngol Head Neck Surg; 2004 Sep; 131(3):271-9. PubMed ID: 15365547 [TBL] [Abstract][Full Text] [Related]
35. [Threshold doses in ototoxicity]. Federspil P HNO; 1984 Oct; 32(10):417-8. PubMed ID: 6334677 [TBL] [Abstract][Full Text] [Related]
36. Proper use of aminoglycosides. Yoshikawa TT Am Fam Physician; 1980 May; 21(5):125-30. PubMed ID: 7377070 [TBL] [Abstract][Full Text] [Related]
37. [Evaluation of cochlear and vestibular functions of patients treated by dibekacin in an E.N.T. unit]. Uziel A; Goubert JL Nouv Presse Med; 1982 Nov; 11(46):3456-8. PubMed ID: 6984174 [TBL] [Abstract][Full Text] [Related]
38. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters. Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218 [TBL] [Abstract][Full Text] [Related]